These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 805483)
21. Clinical aspects of Rh immunization. Philip Levine Award Address. Mollison PL Am J Clin Pathol; 1973 Sep; 60(3):287-301. PubMed ID: 4199486 [No Abstract] [Full Text] [Related]
22. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations. Hendrickson JE; Delaney M Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673 [TBL] [Abstract][Full Text] [Related]
23. Prevention of Rh isoimmunization. Clarke CA Prog Med Genet; 1972; 8():169-223. PubMed ID: 4110995 [No Abstract] [Full Text] [Related]
24. Understanding red blood cell alloimmunization triggers. Hendrickson JE; Tormey CA Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):446-451. PubMed ID: 27913514 [TBL] [Abstract][Full Text] [Related]
25. Fetal-maternal incompatibility in the Rh system. Rh isoimmunization associated with hereditary spherocytosis: case presentation and review of the literature. Neamţu SD; Novac MB; Neamţu AV; Stanca ID; Boldeanu MV; Gluhovschi A; Stanca L; Dijmărescu AL; Manolea MM; Trăistaru MR; Mateescu GO; Siminel MA Rom J Morphol Embryol; 2022; 63(1):229-235. PubMed ID: 36074689 [TBL] [Abstract][Full Text] [Related]
26. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Aygun B; Padmanabhan S; Paley C; Chandrasekaran V Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310 [TBL] [Abstract][Full Text] [Related]
27. Histo-blood group antigens as allo- and autoantigens. Nydegger UE; Tevaearai H; Berdat P; Rieben R; Carrel T; Mohacsi P; Flegel WA Ann N Y Acad Sci; 2005 Jun; 1050():40-51. PubMed ID: 16014519 [TBL] [Abstract][Full Text] [Related]
28. The prevention of rhesus-isoimmunization. Davey M Clin Obstet Gynaecol; 1979 Dec; 6(3):509-30. PubMed ID: 92385 [No Abstract] [Full Text] [Related]
33. [Problems of ABO hemolytic disease in the newborn infant]. Novachev D; Markov L Akush Ginekol (Sofiia); 1980; 19(3):253-7. PubMed ID: 6992621 [No Abstract] [Full Text] [Related]
34. Transfusion support in the management of immune haemolytic disorders. Plapp FV; Beck ML Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130 [No Abstract] [Full Text] [Related]
35. Basic principles of the ABO and Rh blood group systems for hemapheresis practitioners. Sigmon JM J Clin Apher; 1992; 7(3):158-62. PubMed ID: 1286997 [TBL] [Abstract][Full Text] [Related]
36. Clinical significance of antibodies to antigens in the ABO, MNS, P1PK, Rh, Lutheran, Kell, Lewis, Duffy, Kidd, Diego, Yt, and Xg blood group systems. Thornton NM; Grimsley SP Immunohematology; 2019 Sep; 35(3):95-101. PubMed ID: 31621367 [TBL] [Abstract][Full Text] [Related]
37. Alloimmunity to human red blood cell antigens. Urbaniak SJ Vox Sang; 2002 Aug; 83 Suppl 1():293-7. PubMed ID: 12617156 [No Abstract] [Full Text] [Related]
38. Macro- and microdifferences in blood group antigens and antibodies. Wiener AS; Socha WW Int Arch Allergy Appl Immunol; 1974; 47(4):547-61. PubMed ID: 4137838 [No Abstract] [Full Text] [Related]
40. Hot spots in the red cell membrane: molecular aspects of some red cell antigens. Daniels G Immunol Invest; 1995; 24(1-2):199-212. PubMed ID: 7713583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]